Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
RMD Open
|
April 3, 2021
Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction
Yomei Shaw, Delphine S Courvoisier, Almut Scherer, et al.
Plos One
|
May 31, 2019
Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
Monika Hebeisen, Almut Scherer, Raphael Micheroli, et al.
RMD Open
|
June 5, 2023
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
Adrian Ciurea, Andrea Götschi, Seraphina Kissling, et al.
The Journal of Rheumatology
|
January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study
Pascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy
|
June 10, 2021
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
Michael J Nissen, Burkhard Möller, Adrian Ciurea, et al.
Journal of Ultrasonography
|
April 22, 2022
Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort
Raphael Micheroli, Almut Scherer, Kristina Bürki, et al.
Rheumatology (Oxford, England)
|
September 7, 2023
Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts
Burkhard Möller, Godehard A Scholz, Jennifer Amsler, et al.
RMD Open
|
October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Annals of the Rheumatic Diseases
|
June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
Annals of the Rheumatic Diseases
|
August 9, 2014
Age at symptom onset in ankylosing spondylitis: is there a gender difference?
Adrian Ciurea, Almut Scherer, Ulrich Weber, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
RMD Open
|
April 3, 2021
Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction
Yomei Shaw, Delphine S Courvoisier, Almut Scherer, et al.
Plos One
|
May 31, 2019
Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
Monika Hebeisen, Almut Scherer, Raphael Micheroli, et al.
RMD Open
|
June 5, 2023
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
Adrian Ciurea, Andrea Götschi, Seraphina Kissling, et al.
The Journal of Rheumatology
|
January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study
Pascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy
|
June 10, 2021
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
Michael J Nissen, Burkhard Möller, Adrian Ciurea, et al.
Journal of Ultrasonography
|
April 22, 2022
Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort
Raphael Micheroli, Almut Scherer, Kristina Bürki, et al.
Rheumatology (Oxford, England)
|
September 7, 2023
Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts
Burkhard Möller, Godehard A Scholz, Jennifer Amsler, et al.
RMD Open
|
October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Annals of the Rheumatic Diseases
|
June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
Annals of the Rheumatic Diseases
|
August 9, 2014
Age at symptom onset in ankylosing spondylitis: is there a gender difference?
Adrian Ciurea, Almut Scherer, Ulrich Weber, et al.
Page
of 6